HEXIMA LIMITED (ASX:HXL)
Who is HEXIMA LIMITED (ASX:HXL)?
Hexima is a clinical stage, anti-infectives focused biotechnology company engaged in the research and development of plant defensin peptides for applications as human therapeutics. Our lead product candidate, pezadeftide (formally HXP124) applied in a topical formulation, is a potential new prescrip...See more
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Year Founded:
1998 (28 years)
Address:
MELBOURNE, VICTORIA 3086, AU
Employees by Department
- The Rest (2)
- Total (2)
Key Decision Makers
Geoffrey Kempler
Chairman
Justin Y
Non Executive Director
Employees by Seniority
C-level
1employees
Senior
0employees
Non-managers
0employees
Financials
LOW
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has HEXIMA LIMITED (ASX:HXL) been operating for?
- What is the funding status of HEXIMA LIMITED (ASX:HXL)?
- Where is HEXIMA LIMITED (ASX:HXL)'s headquarter?
- What HEXIMA LIMITED (ASX:HXL)'s spending power?
- Does HEXIMA LIMITED (ASX:HXL) have a presence in the domain it operates in?